Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor

Franklin J. Moy, Michal Safran, Andrew P. Seddon, Doug Kitchen, Peter Böhlen, David Aviezer, Avner Yayon, Robert Powers

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Interaction of basic fibroblast growth factor (FGF-2) with heparin or heparan sulfate proteoglycans (HSPGs) is required for receptor activation and initiation of biological responses. To gain insight into the mechanism of activation of the FGF receptor by FGF-2 and heparin, we have used NMR, dynamic light scattering, and HSPG-deficient cells and cell-free systems. The first 28 N-terminal residues in FGF-2 were found to be highly mobile and flexible, consistent with the disorder found in both the NMR and X-ray structures. The structure of an FGF-2-heparin-decasaccharide complex that binds to and activates the FGF receptor was compared to a heparin- tetrasaccharide-induced complex that does not promote an interaction with the receptor. The major change observed upon the addition of the tetrasaccharide to FGF-2 was an increase in the correlation time consistent with the formation of an FGF-2 dimer. The NMR line widths of FGF-2 in the presence of the decasaccharide are severely broadened relative to the tetrasaccharide, consistent with dynamic light scattering results which indicate FGF-2 is a tetramer. The interaction of these heparin species with FGF-2 does not induce a significant conformational change in the overall structure of FGF-2, but small chemical shift changes are observed in both heparin and receptor binding sites. A trans-oriented symmetric dimer of FGF-2 is formed in the presence of the tetrasaccharide whereas two cis-oriented dimers in a symmetric tetramer are formed in the presence of the decasaccharide. This suggests that the cis-oriented FGF-2 dimer is the minimal biologically active structural unit of FGF-2. These data allow us to propose a novel mechanism to explain the functional interaction of FGF-2 with heparin and its transmembrane receptor.

Original languageEnglish (US)
Pages (from-to)4782-4791
Number of pages10
JournalBiochemistry
Volume36
Issue number16
DOIs
StatePublished - Apr 22 1997

Fingerprint

Fibroblast Growth Factor 2
Dimers
Heparin
Fibroblast Growth Factor Receptors
Heparan Sulfate Proteoglycans
Nuclear magnetic resonance
Dynamic light scattering
Chemical activation
Cell-Free System
Chemical shift
Linewidth

ASJC Scopus subject areas

  • Biochemistry

Cite this

Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. / Moy, Franklin J.; Safran, Michal; Seddon, Andrew P.; Kitchen, Doug; Böhlen, Peter; Aviezer, David; Yayon, Avner; Powers, Robert.

In: Biochemistry, Vol. 36, No. 16, 22.04.1997, p. 4782-4791.

Research output: Contribution to journalArticle

Moy, FJ, Safran, M, Seddon, AP, Kitchen, D, Böhlen, P, Aviezer, D, Yayon, A & Powers, R 1997, 'Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor', Biochemistry, vol. 36, no. 16, pp. 4782-4791. https://doi.org/10.1021/bi9625455
Moy, Franklin J. ; Safran, Michal ; Seddon, Andrew P. ; Kitchen, Doug ; Böhlen, Peter ; Aviezer, David ; Yayon, Avner ; Powers, Robert. / Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. In: Biochemistry. 1997 ; Vol. 36, No. 16. pp. 4782-4791.
@article{3ee03c0c84ed4db8ac9fc241d360b9ca,
title = "Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor",
abstract = "Interaction of basic fibroblast growth factor (FGF-2) with heparin or heparan sulfate proteoglycans (HSPGs) is required for receptor activation and initiation of biological responses. To gain insight into the mechanism of activation of the FGF receptor by FGF-2 and heparin, we have used NMR, dynamic light scattering, and HSPG-deficient cells and cell-free systems. The first 28 N-terminal residues in FGF-2 were found to be highly mobile and flexible, consistent with the disorder found in both the NMR and X-ray structures. The structure of an FGF-2-heparin-decasaccharide complex that binds to and activates the FGF receptor was compared to a heparin- tetrasaccharide-induced complex that does not promote an interaction with the receptor. The major change observed upon the addition of the tetrasaccharide to FGF-2 was an increase in the correlation time consistent with the formation of an FGF-2 dimer. The NMR line widths of FGF-2 in the presence of the decasaccharide are severely broadened relative to the tetrasaccharide, consistent with dynamic light scattering results which indicate FGF-2 is a tetramer. The interaction of these heparin species with FGF-2 does not induce a significant conformational change in the overall structure of FGF-2, but small chemical shift changes are observed in both heparin and receptor binding sites. A trans-oriented symmetric dimer of FGF-2 is formed in the presence of the tetrasaccharide whereas two cis-oriented dimers in a symmetric tetramer are formed in the presence of the decasaccharide. This suggests that the cis-oriented FGF-2 dimer is the minimal biologically active structural unit of FGF-2. These data allow us to propose a novel mechanism to explain the functional interaction of FGF-2 with heparin and its transmembrane receptor.",
author = "Moy, {Franklin J.} and Michal Safran and Seddon, {Andrew P.} and Doug Kitchen and Peter B{\"o}hlen and David Aviezer and Avner Yayon and Robert Powers",
year = "1997",
month = "4",
day = "22",
doi = "10.1021/bi9625455",
language = "English (US)",
volume = "36",
pages = "4782--4791",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "16",

}

TY - JOUR

T1 - Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor

AU - Moy, Franklin J.

AU - Safran, Michal

AU - Seddon, Andrew P.

AU - Kitchen, Doug

AU - Böhlen, Peter

AU - Aviezer, David

AU - Yayon, Avner

AU - Powers, Robert

PY - 1997/4/22

Y1 - 1997/4/22

N2 - Interaction of basic fibroblast growth factor (FGF-2) with heparin or heparan sulfate proteoglycans (HSPGs) is required for receptor activation and initiation of biological responses. To gain insight into the mechanism of activation of the FGF receptor by FGF-2 and heparin, we have used NMR, dynamic light scattering, and HSPG-deficient cells and cell-free systems. The first 28 N-terminal residues in FGF-2 were found to be highly mobile and flexible, consistent with the disorder found in both the NMR and X-ray structures. The structure of an FGF-2-heparin-decasaccharide complex that binds to and activates the FGF receptor was compared to a heparin- tetrasaccharide-induced complex that does not promote an interaction with the receptor. The major change observed upon the addition of the tetrasaccharide to FGF-2 was an increase in the correlation time consistent with the formation of an FGF-2 dimer. The NMR line widths of FGF-2 in the presence of the decasaccharide are severely broadened relative to the tetrasaccharide, consistent with dynamic light scattering results which indicate FGF-2 is a tetramer. The interaction of these heparin species with FGF-2 does not induce a significant conformational change in the overall structure of FGF-2, but small chemical shift changes are observed in both heparin and receptor binding sites. A trans-oriented symmetric dimer of FGF-2 is formed in the presence of the tetrasaccharide whereas two cis-oriented dimers in a symmetric tetramer are formed in the presence of the decasaccharide. This suggests that the cis-oriented FGF-2 dimer is the minimal biologically active structural unit of FGF-2. These data allow us to propose a novel mechanism to explain the functional interaction of FGF-2 with heparin and its transmembrane receptor.

AB - Interaction of basic fibroblast growth factor (FGF-2) with heparin or heparan sulfate proteoglycans (HSPGs) is required for receptor activation and initiation of biological responses. To gain insight into the mechanism of activation of the FGF receptor by FGF-2 and heparin, we have used NMR, dynamic light scattering, and HSPG-deficient cells and cell-free systems. The first 28 N-terminal residues in FGF-2 were found to be highly mobile and flexible, consistent with the disorder found in both the NMR and X-ray structures. The structure of an FGF-2-heparin-decasaccharide complex that binds to and activates the FGF receptor was compared to a heparin- tetrasaccharide-induced complex that does not promote an interaction with the receptor. The major change observed upon the addition of the tetrasaccharide to FGF-2 was an increase in the correlation time consistent with the formation of an FGF-2 dimer. The NMR line widths of FGF-2 in the presence of the decasaccharide are severely broadened relative to the tetrasaccharide, consistent with dynamic light scattering results which indicate FGF-2 is a tetramer. The interaction of these heparin species with FGF-2 does not induce a significant conformational change in the overall structure of FGF-2, but small chemical shift changes are observed in both heparin and receptor binding sites. A trans-oriented symmetric dimer of FGF-2 is formed in the presence of the tetrasaccharide whereas two cis-oriented dimers in a symmetric tetramer are formed in the presence of the decasaccharide. This suggests that the cis-oriented FGF-2 dimer is the minimal biologically active structural unit of FGF-2. These data allow us to propose a novel mechanism to explain the functional interaction of FGF-2 with heparin and its transmembrane receptor.

UR - http://www.scopus.com/inward/record.url?scp=0030890997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030890997&partnerID=8YFLogxK

U2 - 10.1021/bi9625455

DO - 10.1021/bi9625455

M3 - Article

C2 - 9125499

AN - SCOPUS:0030890997

VL - 36

SP - 4782

EP - 4791

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 16

ER -